Icon PLC (ICLR): Total Assets
$16.27B
As of 2025-12-31
-1.8%
3-year compound annual growth
+36.5%
5-year compound annual growth
+25.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $16.27B | -2.2% | 2026-05-27, Balance as of period end |
| 2024-12-31 | $16.63B | -1.4% | 2026-05-27, Balance as of period end |
| 2023-12-31 | $16.86B | -1.9% | 2026-05-27, Balance as of period end |
| 2022-12-31 | $17.19B | -1.2% | 2024-02-23, Balance as of period end |
| 2021-12-31 | $17.39B | +406.1% | 2023-02-24, Balance as of period end |
| 2020-12-31 | $3.44B | +18.2% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $2.91B | +23.5% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $2.35B | +9.7% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $2.15B | +17.6% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $1.83B | +6.3% | 2018-02-28, Balance as of period end |
| 2015-12-31 | $1.72B | +12.3% | 2017-02-28, Balance as of period end |
| 2014-12-31 | $1.53B | +6.0% | 2016-03-23, Balance as of period end |
| 2013-12-31 | $1.44B | +20.0% | 2015-03-12, Balance as of period end |
| 2012-12-31 | $1.20B | +17.0% | 2014-03-12, Balance as of period end |
| 2011-12-31 | $1.03B | +8.2% | 2013-03-06, Balance as of period end |
| 2010-12-31 | $949.54M | +4.5% | 2012-03-02, Balance as of period end |
| 2009-12-31 | $908.40M | n/a | 2011-03-22, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Icon PLC (ICLR) | 2025-12-31 | $16.27B | -2.2% |
| Incyte Corp (INCY) | 2025-12-31 | $6.96B | +27.8% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $29.94B | +11.3% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $7.14B | -5.2% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $1.98B | -6.0% |
| NRC Health (NRC) | 2025-12-31 | $134.88M | +1.8% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $202.51M | -15.4% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $300.91M | -7.6% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $44.58M | +6.9% |
Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗